#26 What's trending in pharmacovigilance? – Angela Caro-Rojas Artwork

Drug Safety Matters

Drug Safety Matters brings you the best stories from the world of pharmacovigilance. Through in-depth interviews with our guests, we cover new research and trends, and explore the most pressing issues in medicines safety today. Produced by Uppsala Monitoring Centre, the WHO Collaborating Centre for International Drug Monitoring.

The views and opinions expressed in the podcast are those of the hosts and guests respectively and, unless otherwise stated, do not represent the position of any institution to which they are affiliated.

All Episodes

Drug Safety Matters

#26 What's trending in pharmacovigilance? – Angela Caro-Rojas

December 20, 2023 • Uppsala Monitoring Centre

0:00 | 28:06

Send a text message to the show!

What did the drug safety community achieve in 2023 and how will the field develop in 2024? As the year comes to a close, we asked Angela Caro-Rojas, president of the International Society of Pharmacovigilance (ISoP), to walk us through current and future trends in pharmacovigilance.

Tune in to find out:

Why patient engagement is a growing priority
What challenges exist in the Latin American region
Which topics will be in the spotlight next year

Want to know more?

ISoP is a non-profit society open to anyone with an interest in pharmacovigilance.

Through 14 chapters and 13 special interest groups, the society works to enhance the safe and proper use of medicines across countries.

Their latest annual meeting took place in Bali, Indonesia in November 2023, while the next one will take place in Montreal, Canada in October 2024.

To learn more about ISoP’s activities in patient engagement and pharmacogenomics, listen to these episodes from the Drug Safety Matters archive:

Got a story to share?
We’re always looking for new topics and interesting voices. If you have an idea or any other feedback for the show, get in touch!

About UMC
Uppsala Monitoring Centre promotes safer use of medicines and vaccines for everyone everywhere. Follow us on Facebook, LinkedIn, X, and Bluesky.